As of 2026-04-04, the Relative Valuation of Amicus Therapeutics Inc (FOLD) is (0.90) USD. This relative valuation is based on P/E multiples. With the latest stock price at 14.44 USD, the upside of Amicus Therapeutics Inc based on Relative Valuation is -106.2%.
The range of the Relative Valuation is (1.82) - 0.32 USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 21.1x - 24.2x | 24.0x |
| Forward P/E multiples | 21.0x - 26.1x | 21.9x |
| Fair Price | (1.82) - 0.32 | (0.90) |
| Upside | -112.6% - -97.8% | -106.2% |
| Date | P/E |
| 2026-04-02 | -167.25 |
| 2026-04-01 | -167.25 |
| 2026-03-31 | -167.48 |
| 2026-03-30 | -167.13 |
| 2026-03-27 | -166.90 |
| 2026-03-26 | -167.13 |
| 2026-03-25 | -167.13 |
| 2026-03-24 | -166.90 |
| 2026-03-23 | -167.02 |
| 2026-03-20 | -167.13 |
| 2026-03-19 | -166.56 |
| 2026-03-18 | -166.44 |
| 2026-03-17 | -166.44 |
| 2026-03-16 | -166.44 |
| 2026-03-13 | -166.44 |
| 2026-03-12 | -166.44 |
| 2026-03-11 | -166.44 |
| 2026-03-10 | -166.32 |
| 2026-03-09 | -166.44 |
| 2026-03-06 | -166.09 |
| 2026-03-05 | -165.98 |
| 2026-03-04 | -165.98 |
| 2026-03-03 | -166.09 |
| 2026-03-02 | -166.32 |
| 2026-02-27 | -166.44 |
| 2026-02-26 | -165.98 |
| 2026-02-25 | -166.09 |
| 2026-02-24 | -166.32 |
| 2026-02-23 | -166.32 |
| 2026-02-20 | -166.09 |
| 2026-02-19 | -166.21 |
| 2026-02-18 | -166.09 |
| 2026-02-17 | -165.63 |
| 2026-02-13 | -165.74 |
| 2026-02-12 | -165.98 |
| 2026-02-11 | -165.74 |
| 2026-02-10 | -165.63 |
| 2026-02-09 | -165.63 |
| 2026-02-06 | -165.63 |
| 2026-02-05 | -165.40 |
| 2026-02-04 | -165.28 |
| 2026-02-03 | -165.40 |
| 2026-02-02 | -165.51 |
| 2026-01-30 | -165.51 |
| 2026-01-29 | -165.28 |
| 2026-01-28 | -165.40 |
| 2026-01-27 | -165.51 |
| 2026-01-26 | -165.51 |
| 2026-01-23 | -165.28 |
| 2026-01-22 | -165.28 |